FDA Inspection 1247772 — Nephron SC, LLC

Nephron SC, LLC — FEI 3010892830

The FDA completed an inspection of Nephron SC, LLC on September 25, 2024 in West Columbia, SC. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 25, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Columbia, SC (United States)

Citations

IDCFRDescription
143021 CFR 211.42(c)(10)(i)Floors, walls, ceiling surfaces
143321 CFR 211.42(c)(10)(iii)Air Supply
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
145121 CFR 211.113(b)Procedures for sterile drug products
202721 CFR 211.192Investigations of discrepancies, failures